Business Context and Reporting Period
This Form 8-K is a current report filed by resTORbio, Inc. (not Adicet Bio, Inc.) on July 6, 2020. The company is incorporated in Delaware and trades on the Nasdaq Global Select Market under the symbol TORC. The report addresses a specific corporate governance event occurring in July 2020.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The primary material change reported is the resignation of John McCabe from his position as Senior Vice President of Finance and principal financial and accounting officer, effective July 31, 2020. Upon his departure, Chen Schor, the Company's President and Chief Executive Officer, will assume the role of principal financial and accounting officer.
Management Commentary and Risks
Management explicitly stated that Mr. McCabe's decision to resign was not related to any disagreements with the Company regarding accounting, strategy, management, operations, policies, regulatory matters, or practices. No other risks, contingencies, or unusual items were disclosed in this filing.
Key Facts for Investor Verification
- John McCabe is resigning as Senior Vice President of Finance effective July 31, 2020.
- Chen Schor (CEO) will temporarily serve as the principal financial and accounting officer.
- The resignation is not attributed to any disagreement with the company.
- The registrant is resTORbio, Inc., not Adicet Bio, Inc.